Insider Selling: Geoffrey T. Barker Sells 10,000 Shares of RPX Corp. Stock (RPXC)
RPX Corp. (NASDAQ:RPXC) Director Geoffrey T. Barker sold 10,000 shares of the stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $15.16, for a total transaction of $151,600.00. Following the completion of the transaction, the director now directly owns 279,399 shares in the company, valued at approximately $4,235,689. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of RPX Corp. (NASDAQ:RPXC) traded down 0.99% during mid-day trading on Wednesday, hitting $15.05. 133,075 shares of the company’s stock traded hands. RPX Corp. has a 52-week low of $14.55 and a 52-week high of $18.75. The stock’s 50-day moving average is $15.79 and its 200-day moving average is $16.32. The company has a market cap of $808.5 million and a P/E ratio of 24.05.
RPX Corp. (NASDAQ:RPXC) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $0.24 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.22 by $0.02. The company had revenue of $64.30 million for the quarter, compared to the consensus estimate of $63.72 million. During the same quarter last year, the company posted $0.26 earnings per share. RPX Corp.’s revenue was up 16.9% compared to the same quarter last year. On average, analysts predict that RPX Corp. will post $0.97 earnings per share for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Barclays downgraded shares of RPX Corp. from an “overweight” rating to an “equal weight” rating in a research note on Monday, August 4th. They now have a $17.00 price target on the stock, down previously from $20.00. Analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of RPX Corp. in a research note on Monday, July 21st. They now have a $19.00 price target on the stock, up previously from $18.50.
RPX Corporation (NASDAQ:RPXC) provides patent risk management solutions, offering defensive buying, acquisition syndication, patent intelligence and advisory services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.